Market Place
Sourcing Support
Delcath Reports Inducement Grants Under Nasdaq Rule
20 Sep 2024 //
BUSINESSWIRE
Delcath Presents HEPZATO KIT Data At ESMO 2024
16 Sep 2024 //
BUSINESSWIRE
Delcath Systems Reports Second Quarter 2024 Results and Business Highlights
05 Aug 2024 //
BUSINESSWIRE
Delcath Systems to Host Second Quarter 2024 Earnings Call
22 Jul 2024 //
BUSINESSWIRE
Casi Pharma RenewsExclusive Distribution Agreement For Evomela
04 Mar 2022 //
PRNEWSWIRE
TAK1 blocker teams up with chemo to kill myeloma cells: study
18 Oct 2021 //
FIERCEBIOTECH
CASI Pharma Announces Launch of EVOMELA® (melphalan injection) in China
12 Aug 2019 //
PR NEWSWIRE
Takeda suffers another setback in its quest to expand myeloma drug’s reach
06 Jun 2019 //
ENDPTS
Deals and M&As this week: Alnylam Pharmaceuticals, Novartis
25 Jan 2019 //
PHARMA TECH
Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M
18 Jan 2019 //
MEDCITY NEWS
Janssen bags new EU approval for Darzalex
04 Sep 2018 //
PHARMA TIMES
Janssen Announces EC Approval of Darzalex (daratumumab) for MM
31 Aug 2018 //
BUSINESSWIRE
Safety scuppers combo trials with J&J/Genmab’s Darzalex
31 May 2018 //
PM LIVE
J&J preps for esketamine filing in resistant depression
08 May 2018 //
FIERCE BIOTECH
CASI Pharmaceuticals Provides Update On EVOMELA®
06 Apr 2018 //
PRNEWSWIRE
Dr Reddy`s rolls out generic Melphalan Hydrochloride cancer injection in US
27 Dec 2017 //
BUSINESS-STANDRAD
J&J’s Darzalex shows promise in newly-diagnosed multiple myeloma
13 Dec 2017 //
PHARMA TIMES
J&J`s Darzalex wins big in first-line myeloma
12 Dec 2017 //
FIERCE PHARMA
Old Cancer Drug Gets 1,227% Price Hike in Frugal U.K.
31 Jan 2017 //
BLOOMBERG
CASI Import Drug Registration Application For Evomela Accepted For Review
05 Dec 2016 //
PR NEWSWIRE
NICE rejects earlier use of multiple myeloma drugs
14 Nov 2016 //
PHARMATIMES
Italian pharma scandals prompts call for EU-wide pricing probe
19 Oct 2016 //
PMLIVE
Par Sterile Products ANDA Melphalan Hydrochloride Approved in US
22 Aug 2016 //
FDA
Spectrum Pharm`s Evomela(Melphalan) approved in US as a chemotherapy drug
10 Mar 2016 //
FDA
Delcath Announces Initiation Of Phase 3 Trial Of Melphalan/HDS System
20 Jan 2016 //
PR NEWSWIRE
Alvogen To Buy Product Portfolio From Pfizer For U.S. Market
27 Aug 2015 //
NASDAQ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.